ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $64.4B | $61.2B | $56.3B | $54.3B | $58.1B | $56.2B | $45.8B | $33.3B | $32.8B | $28.2B | $25.6B | $22.9B | $20.0B | $18.8B | $18.4B | $17.4B |
| Cost of revenue | $18.4B | $18.2B | $16.9B | $20.4B | $17.4B | $17.4B | $15.4B | $7.4B | $7.7B | $7.0B | $5.8B | $4.5B | $4.4B | $4.6B | $4.5B | $4.6B |
| Gross profit | $46.0B | $43.0B | $39.4B | $33.9B | $40.6B | $38.8B | $30.4B | $25.8B | $25.0B | $21.2B | $19.8B | $18.4B | $15.5B | $14.2B | $13.9B | $12.8B |
| R&D | $9.7B | $9.1B | $12.8B | $7.7B | $6.5B | $6.9B | $6.4B | $6.4B | $10.3B | $5.0B | $4.4B | $4.3B | $3.3B | $2.9B | $2.8B | $2.6B |
| SG&A | $14.7B | $14.0B | $14.8B | $12.9B | $15.3B | $12.3B | $11.3B | $6.9B | $7.4B | $6.3B | $5.9B | $6.4B | $7.7B | $5.4B | $5.0B | $5.9B |
| Other operating expenses | $4.8B | $4.8B | $2.8B | $599M | $753M | $1.6B | $1.4B | — | $924M | $327M | $200M | $150M | $1.1B | $338M | $288M | $673M |
| Operating income | $16.9B | $15.1B | $9.1B | $12.8B | $18.1B | $17.9B | $11.4B | $13.0B | $6.4B | $9.5B | $9.3B | $7.5B | $3.4B | $5.7B | $5.8B | $3.6B |
| Non-operating income | −$8.2B | −$8.5B | −$5.4B | −$6.5B | −$4.6B | −$4.9B | −$8.0B | −$4.6B | −$1.2B | −$1.8B | −$1.5B | −$892M | −$1.0B | −$332M | −$92M | $48M |
| Pretax income | $8.7B | $6.6B | $3.7B | $6.3B | $13.5B | $13.0B | $3.4B | $8.4B | $5.2B | $7.7B | $7.9B | $6.6B | $2.4B | $5.3B | $5.7B | $3.7B |
| Taxes | $2.4B | $2.4B | −$562M | $1.4B | $1.6B | $1.4B | −$1.2B | $544M | −$490M | $2.4B | $1.9B | $1.5B | $595M | $1.2B | $450M | $235M |
| Net income | $6.3B | $4.2B | $4.3B | $4.9B | $11.8B | $11.5B | $4.6B | $7.9B | $5.7B | $5.3B | $6.0B | $5.1B | $1.8B | $4.1B | $5.3B | $3.4B |
| Diluted EPS | $3.54 | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 | $2.72 | $5.28 | $3.66 | $3.30 | $3.63 | $3.13 | $1.10 | $2.56 | $3.35 | $2.18 |
| Diluted shares | — | 1.77B | 1.77B | 1.77B | 1.78B | 1.78B | 1.67B | 1.48B | 1.55B | 1.60B | 1.63B | 1.64B | 1.61B | 1.60B | 1.58B | 1.58B |
| Revenue growth | — | +8.6% | +3.7% | −6.4% | +3.3% | +22.7% | +37.7% | +1.6% | +16.1% | +10.1% | +12.2% | +14.5% | +6.2% | +2.2% | +5.4% | — |
| Gross margin | 71.5% | 70.2% | 70.0% | 62.4% | 70.0% | 69.0% | 66.4% | 77.6% | 76.4% | 75.0% | 77.3% | 80.3% | 77.8% | 75.6% | 75.5% | 73.4% |
| Operating margin | 26.2% | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 33.8% | 36.4% | 33.0% | 17.1% | 30.1% | 31.6% | 20.8% |
| Net margin | 9.8% | 6.9% | 7.6% | 9.0% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% | 22.5% | 8.9% | 22.0% | 28.7% | 19.7% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.